Related Experiment Video

Updated: Jun 23, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Neuroimaging findings in children with paediatric neurotransmitter diseases

Wang-Tso Lee1, Wen-Chin Weng, Shinn-Forng Peng

  • 1Department of Pediatrics, National Taiwan University Hospital, 7, Chung-Shan South Road, Taipei 100, Taiwan. leeped@hotmail.com

Journal of Inherited Metabolic Disease
|May 21, 2009
PubMed

Insights

Diagnosing inherited paediatric neurotransmitter diseases is challenging. Neuroimaging and evaluating dopaminergic transmission are crucial for diagnosing these rare neurometabolic disorders in children.

Area of Science:

  • Neurology
  • Metabolic Disorders
  • Neuroimaging

Background:

  • Paediatric neurotransmitter diseases are inherited neurometabolic disorders affecting children.
  • Diagnosis is challenging, requiring multiple assessment methods.
  • These disorders involve neurotransmitter metabolism, including GABA and monoamines.

Purpose of the Study:

  • To highlight the importance of neuroimaging in diagnosing paediatric neurotransmitter diseases.
  • To emphasize the role of functional evaluation of dopaminergic transmission in specific disorders.
  • To provide valuable insights for clinicians investigating these rare conditions.

Main Methods:

  • Review of clinical manifestations.
  • Cerebrospinal fluid (CSF) neurotransmitter level measurement.
  • Analysis of neuroimaging findings.
  • Functional evaluation of dopaminergic transmission for monoamine biosynthesis disorders.

Main Results:

  • Neuroimaging findings offer significant diagnostic information.
  • CSF neurotransmitter measurements are essential.
  • Dopaminergic transmission evaluation is key for monoamine disorders.

Conclusions:

  • Understanding neuroimaging patterns aids in diagnosing paediatric neurotransmitter diseases.
  • Integrated diagnostic approaches improve patient evaluation.
  • Further research into neuroimaging in these diseases is valuable.

More Related Videos

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging12:21

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging

Published on: September 12, 2011

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)10:02

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Published on: March 12, 2020

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...